Old Web
English
Sign In
Acemap
>
authorDetail
>
M M Mangada
M M Mangada
Medicine
Integrin
Pharmacokinetics
Pharmacology
α4β7 integrin
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P306 MORF-057, an oral selective α4β7 integrin inhibitor for Inflammatory Bowel Disease, leads to specific target engagement in a single and multiple ascending dose study in healthy subjects
2021
Journal of Crohn's and Colitis
A. S. Ray
D. Cui
D. Lee
M M Mangada
Jennifer Jones
G. Bain
P G Traber
L H Vrishabhendra
P W Krzeski
N. Vande Casteele
M M Reardon
T P Stern
C.L. Soo
H. Nguyen
B. N. Rogers
P G Linde
Show All
Source
Cite
Save
Citations (1)
P037 Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion properties of MORF-057 support its clinical development as an oral selective α4β7 integrin inhibitor
2021
Journal of Crohn's and Colitis
J. Jones
D. Lee
I Smukste
D. Cui
M. G. Bursavich
D Troast
C. Zhong
J.E. Wong
M M Mangada
G. Bain
B Lippa
A. S. Ray
B. N. Rogers
Show All
Source
Cite
Save
Citations (0)
1